Tutto oggi a star male con giramenti fi testa e mal di stomaco, ora si è aggiunta pure la febbre. Potrei non suoerare la notte. Secquesto docesse essere il mio ultimo post, sappiate che ho sempre amato #clubbez.
Tutto oggi a star male con giramenti fi testa e mal di stomaco, ora si è aggiunta pure la febbre. Potrei non suoerare la notte. Secquesto docesse essere il mio ultimo post, sappiate che ho sempre amato #clubbez.
L’#universo ha circa 13,787 miliardi di anni, con un margine di errore di 20 milioni di anni. A seconda delle #teorie sulla sua eventuale #fine, è ancora praticamente all'inizio della sua "#vita", oppure quasi a metà.
#curiosiclubbez #scienza #virale #natura #spazio #clubbez
Viral Clearance and Viral Testing Services
Considering the rising demand for biologics, innovators in the biopharmaceutical industry are constantly exploring avenues that would enable them to overcome the existing technical and operational challenges related to viral-clearance and testing for timely approval of biologics.
Outsourcing the viral clearance and viral testing studies has emerged as a promising alternative for most of the manufacturers. Despite being one of the crucial steps amongst all the steps involved in the production of biologics, this service is heavily outsourced in the biopharmaceutical industry. Currently, it is estimated that more than 70% of these services are employed by biopharmaceutical and pharmaceutical companies. Service providers across the globe offering this service are large players.
Of these, close to 80% players provide services for both, viral clearance and viral testing of different type of biologics. Of the players have established their facilities in Europe. Within this region, UK has the maximum number of facilities (over 21%), followed by Germany (more than 15%) and France (close to 10%). Patents have been filed / granted over last few years. Of these, over 40% patents are granted by organizations headquartered in the US whereas close to 25% patent applications are filed by organizations headquartered in China.
As projected by Roots Analysis, more than 55% of the share is captured by viral removal, in the viral clearance market. As projected by Roots Analysis, 40% of the share is captured by North America, in this market. Driven by the rising interest in research and development activities and the demand for the viral clearance and viral testing services, the future opportunities and growth associated with this market are anticipated to witness a noteworthy growth in the foreseen future. Specifically, in terms of end-users, the market is anticipated to be driven by biotechnology and pharmaceutical industry.
For additional details, please visit
https://www.rootsanalysis.com/....blog/viral-clearance or email sales@rootsanalysis.com
You may also be interested in the following titles:
1. Smart Labels Market: Industry Trends and Global Forecasts, 2022-2035
2. 4D Bioprinting Market : Industry Trends and Global Forecasts, 2022-2035
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
Continuano i #curiosiclubbez sull'#amore per celebrare #sanvalentino! Innamorarsi produce diverse sostanze chimiche che inducono euforia e stimolano 12 aree del #cervello contemporaneamente. Una è l'#ossitocina, il cosiddetto ormone dell'amore o dell'#abbraccio, si produce proprio nel momento in cui ci si abbraccia. L'ormone appare nel cervello e si pensa sia coinvolto nel processo di unione tra 2 persone.
#virale #natura #vita #scienza #clubbez
#sanvalentino Festa degli #innamorati.... Ma dato che io sono solo e cinico, beccatevi la #storia vera.
#amore
https://www.focus.it/cultura/s....toria/san-valentino-
Visto che è #sanvalentino riproponiamo la #curiosiclubbez su chi si ama per sempre e con #devozione. Circa il 90% delle specie di #uccelli conosciute sono monogame. Molti non cercano altri #partner neppure dopo la morte del compagno.
#virale #amore #natura #vita #animali #clubbez
Artificial Intelligence (AI) In Oncology: Current Scenario and Future Potential
In the last decade, the popularity of AI has grown invariably. It has made a considerable impact in the medical sector and oncologic treatment as well, due to a surge in electronic data, breakthroughs in technological infrastructure and groundbreaking research in deep learning neural networks.
AI has demonstrated potential in improving tumor imaging diagnosis and therapy response evaluation, anticipating clinical outcomes, and accelerating drug development and translational oncology. AI has the potential to revolutionize the oncology sector, by overcoming the existing challenges, by leveraging the power of big data to further improve the cancer treatment. Although AI is already being used in oncology clinical practice, ongoing and increased efforts are required to allow AI to reach its full potential.
AI in Oncology Market – Current Market Landscape
Currently, over 76 industry players worldwide are actively engaged in the development of AI in oncology- based software solutions. The market is characterized by a mix of well-established and small firms. Several industry players involved in the development of AI in oncology- based software solutions are majorly providing these services for cancer diagnosis, along with drug development and drug discovery. Majority of the software providers have their platforms on cloud, for end users which include, hospitals, pharmaceutical companies and research institutes. The growing pipeline and the increasing demand for effective diagnosis of cancer indications at an early stage using AI to prevent malignancies, has spurred the establishment of many companies in the last decades; currently, AI in diagnostics market is dominated by companies based in North America, majority of them being small sized.
Mutually Beneficial Partnerships in Order to Expand Capacities to Keep Pace with the Growing Demand
Several partnerships have been established by various stakeholders engaged in the development of Artificial Intelligence in oncology-based software solutions in the past 5 years; there has been a significant increase in partnership activity in this domain, growing at a CAGR of 36%, during the period 2017-2022.
Surge in Funding Activity in this Domain Foreseeing Lucrative Returns
There has been a steady increase in the funding activity within this domain during the period 2017-2022 which amounted to more than USD 5.9 billion.
High Number of Patents are Suggestive of the Widespread Research in this Domain
Several industry and non-industry players are involved in the development of Artificial Intelligence in Oncology- based software solutions. Over 2,770 patents have been granted / filed by academic and industry stakeholders till date.
Future Evolution of AI in Oncology Market
Owing to the anticipated AI in the oncology sector and given the fact that several new players have entered the domain in the last decade, who are actively collaborating with other industry / non-industry players to expand the global reach of this domain the market opportunity associated with AI in oncology is anticipated to grow at a CAGR of 54%.
For additional details, please visit https://www.rootsanalysis.com/blog/ai-in-oncology/ or email sales@rootsanalysis.com
You may also be interested in the following titles:
1. Smart Labels Market: Industry Trends and Global Forecasts, 2022-2035
2. AI-based Digital Pathology / AI Pathology Market: Industry Trends and Global Forecasts, 2022-2035
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
Ora, non vorrei generare flame, di solito cerco di evitare di parlare di #politica perché si finisce in caciara, ma... perché fanno ancora parlare #berlusconi?
#silvioritirati
la butto lì
https://www.lucianopignataro.i....t/a/miglio-osterie-t
annarita
Elimina il commento
Sei sicuro di voler eliminare questo commento ?